Revascularization Treatment in Patients with Coronary Artery Disease

Overview

Journal Hippokratia

Specialty General Medicine

Date 2008 Oct 17

PMID 18923757

Citations 6

Authors

S G Foussas

G Z Tsiaousis

Affiliations

Soon will be listed here.

Abstract

The choice of optimal revascularization strategy in patients with coronary artery disease (CAD) is becoming more challenging lately, due to recent advances in percutaneous coronary intervention (PCI) and coronary artery bypass grafting surgery (CABG). On one hand, drug-eluting stents (DES) have emerged as a solution to the problem of restenosis after balloon angioplasty or bare-metal stent implantation, which was responsible for a higher rate of events (mainly repeat revascularization) in relation to CABG. On the other hand, off-pump bypass techniques and minimally invasive grafting of the left anterior descending artery appear to be safe and efficacious alternatives to traditional, on-pump CABG. Available literature includes studies outdated by current technologies, leaving the dilemma of best revascularization strategy unanswered in the general CAD population, but also in high-risk groups, such as diabetics and patients with chronic kidney disease. A number of ongoing trials, especially designed for this purpose, are set to end the debate, providing headto- head comparisons between DES-assisted PCI and contemporary bypass surgery.

Citing Articles

Collateral Development in Patients Undergoing Coronary Angiography in a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Gautam A, Dhital B, Pokhrel M, Kafle A JNMA J Nepal Med Assoc. 2023; 60(252):707-709.

PMID: 36705220 PMC: 9446487. DOI: 10.31729/jnma.7542.

The role of Cardiac Magnetic Resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review.

Mayala H, Bakari K, Zhaohui W Malawi Med J. 2019; 31(3):241-245.

PMID: 31839897 PMC: 6895381. DOI: 10.4314/mmj.v31i3.14.

The role of cardiac magnetic resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review.

Mayala H, Bakari K, Zhaohui W Malawi Med J. 2019; 30(4):291-295.

PMID: 31798809 PMC: 6863424. DOI: 10.4314/mmj.v30i4.13.

Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis.

Ju C, Li Y, Shen Y, Liu Y, Cai J, Liu N J Cardiovasc Transl Res. 2018; 11(5):429-437.

PMID: 30276617 PMC: 6413496. DOI: 10.1007/s12265-018-9824-y.

Population-level differences in revascularization treatment and outcomes among various United States subpopulations.

Graham G, Xiao Y, Rappoport D, Siddiqi S World J Cardiol. 2016; 8(1):24-40.

PMID: 26839655 PMC: 4728105. DOI: 10.4330/wjc.v8.i1.24.

References

Hueb W, Lopes N, Gersh B, Soares P, Machado L, Jatene F . Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007; 115(9):1082-9. DOI: 10.1161/CIRCULATIONAHA.106.625475. View

Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J . Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol. 2001; 37(1):51-8. DOI: 10.1016/s0735-1097(00)01052-4. View

. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996; 335(4):217-25. DOI: 10.1056/NEJM199607253350401. View

Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C . Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006; 98(1):54-9. DOI: 10.1016/j.amjcard.2006.01.070. View

Herzog C, Ma J, Collins A . Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002; 106(17):2207-11. DOI: 10.1161/01.cir.0000035248.71165.eb. View

Daemen J, Tanimoto S, Garcia-Garcia H, Kukreja N, van de Sande M, Sianos G . Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol. 2007; 99(8):1027-32. DOI: 10.1016/j.amjcard.2006.11.070. View

Ix J, Mercado N, Shlipak M, Lemos P, Boersma E, Lindeboom W . Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005; 149(3):512-9. DOI: 10.1016/j.ahj.2004.10.010. View

Farkouh M, Dangas G, Leon M, Smith C, Nesto R, Buse J . Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008; 155(2):215-23. DOI: 10.1016/j.ahj.2007.10.012. View

Kapur A, Malik I, Bagger J, ANDERSON J, Kooner J, Thomas M . The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J. 2005; 149(1):13-9. DOI: 10.1016/j.ahj.2004.07.001. View

10.

Ong A, Serruys P, Mohr F, Morice M, Kappetein A, Holmes Jr D . The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006; 151(6):1194-204. DOI: 10.1016/j.ahj.2005.07.017. View

11.

Jaffery Z, Kowalski M, Weaver W, Khanal S . A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 2007; 31(4):691-7. DOI: 10.1016/j.ejcts.2007.01.018. View

12.

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

13.

Zhang R, Ni J, Zhang J, Hu J, Yang Z, Zhang Q . Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J (Engl). 2006; 119(14):1176-81. View

14.

Foussas S, Tsiaousis G . Coronary revascularisation in patients with chronic renal disease. Hellenic J Cardiol. 2007; 48(4):218-27. View

15.

Kupferwasser L, Amorn A, Kapoor N, Lee M, Kar S, Cercek B . Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheter Cardiovasc Interv. 2007; 70(1):1-8. DOI: 10.1002/ccd.21083. View

16.

Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M . Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol. 2007; 49(19):1924-30. DOI: 10.1016/j.jacc.2007.01.081. View

17.

Puskas J, Williams W, Mahoney E, Huber P, Block P, Duke P . Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004; 291(15):1841-9. DOI: 10.1001/jama.291.15.1841. View

18.

Groeneveld P, Suh J, Matta M . The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review. J Interv Cardiol. 2007; 20(1):1-9. DOI: 10.1111/j.1540-8183.2007.00214.x. View

19.

Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D . Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006; 355(11):1093-104. DOI: 10.1056/NEJMoa062006. View

20.

Hermiller J, Raizner A, Cannon L, Gurbel P, Kutcher M, Wong S . Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005; 45(8):1172-9. DOI: 10.1016/j.jacc.2004.10.075. View